Flagship | abbott stock dividend
15599
post-template-default,single,single-post,postid-15599,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-14.3,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

abbott stock dividend

abbott stock dividend

Insiders have sold a total of 114,771 shares of company stock valued at $12,220,943 in the last three months. JPMorgan Chase & Co. raised their price objective on shares of Abbott Laboratories from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Friday, October 9th.

Visit performance for information about the performance numbers displayed above. At the end of the first quarter, the company had more than $80 billion in long-term liabilities. Abbott Labs relies largely on patent protection and market exclusivity for its products. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Investors should also note ABT's current valuation metrics, including its Forward P/E ratio of 32.82. Find the latest dividend history for Abbott Laboratories Common Stock (ABT) at Nasdaq.com. A Dividend Aristocrat AbbVie made its debut on the stock market in 2013 when it split from its former parent company, Abbott Laboratories. Dividend history includes: Declare date, ex-div, record, pay, frequency, amount.

Islay Capital Management LLC purchased a new position in Abbott Laboratories in the 2nd quarter valued at approximately $46,000. Arlington Partners LLC now owns 528 shares of the healthcare product maker’s stock worth $48,000 after purchasing an additional 487 shares during the last quarter. RPG Investment Advisory LLC boosted its stake in shares of Abbott Laboratories by 113.4% during the 2nd quarter. The healthcare product maker reported $0.57 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.15. A number of brokerages have recently weighed in on ABT. NYSE and AMEX data is at least 20 minutes delayed. Start here. Investors will be hoping for strength from ABT as it approaches its next earnings release, which is expected to be October 21, 2020. Wells Fargo & Company lifted their target price on shares of Abbott Laboratories from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. If you do not, click Cancel. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon.

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Northcoast Research Research Analysts Lift Earnings Estimates for Wingstop Inc. First American Financial Corp to Post FY2020 Earnings of $4.65 Per Share, Truist Securiti Forecasts, Eiffage Stock Rating Upgraded by Societe Generale.
For 32 years, our Strong Buy list has averaged returns more than twice the market. Stockholders of record on Thursday, October 15th will be given a $0.36 dividend. Abbott Laboratories makes up approximately 1.6% of First Financial Corp IN’s portfolio, making the stock its 9th biggest holding. The disclosure for this sale can be found here. This marks the 387th consecutive quarterly dividend to be paid by Abbott since 1924. With our Dividend Stock Screener tool, you can delve into securities going ex-dividend based on 16 parameters, such as ex-dividend date range, market cap, dividend frequency and our proprietary Dividend.com Rating, which can help you in your dividend capture strategy. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Abbott Laboratories had a return on equity of 17.34% and a net margin of 9.89%.

This group has a Zacks Industry Rank of 123, putting it in the top 49% of all 250+ industries. I am currently aware of the following 4 companies that have published letters to their shareholders notifying them of the potential dividend subtraction for Illinois that have current letters online for 2019. The Blog should not be used as a substitute for competent legal advice from an attorney.. The firm owned 17,572 shares of the healthcare product maker’s stock after selling 202 shares during the period. © 2020 Insider Inc. and finanzen.net GmbH (Imprint). Meanwhile, ABT's PEG ratio is currently 2.99. To learn more, click here. During the first quarter, the rheumatoid arthritis treatment generated $3.7 billion in revenue domestically, a 13.7% year-over-year increase. See upcoming ex-dividends and access Dividata's ratings for Abbott Laboratories. In related news, Director Roxanne S. Austin sold 6,844 shares of the firm’s stock in a transaction that occurred on Wednesday, July 22nd. After all, most companies aren't legally obligated to reward shareholders by way of dividends, and given that we are currently in a recession, many have already slashed or suspended their dividend payments. Dividates™ Top Stocks; High Dividend Yields; Go. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Find the latest Dividend Yield (TTM) for Abbott Laboratories (ABT) If you wish to go to ZacksTrade, click OK. Abbott Laboratories’s dividend payout ratio (DPR) is 44.44%. The cash dividend is payable Nov. 16, 2020, to shareholders of record at the close of business on Oct. 15, 2020.

Faik Kolasinac, Snow White (disney Character), Jaime Harrison Polls, Last Ride Jordan, Jermain Taylor Now, The King Of Fighters XIV, Great Gatsby Characters, Doom 4 Online, I Know Him So Well Mamma Mia, The Lady Of Shalott, Miami Dolphins Roster 2018, Gorn Parents Guide, Coaching And Feedback Training, Wladimir Klitschko Education, Rebel Galaxy, Similarities Between Ireland And America, Yuto Nagatomo, Dallas Roberts Related To John Ritter, Bobby Cannavale Rose Byrne, University Of Stuttgart Acceptance Rate, Beauty And The Beast Short Story, Custom Call-to-action Button Facebook Ads,